Guangdong Zhongsheng Pharmaceutical Overview

  • Year Founded
  • 1979

Year Founded

  • Status
  • Public

  • Employees
  • 1,757

Employees

  • Stock Symbol
  • 002317

Stock Symbol

  • Investments
  • 7

  • Share Price
  • $3.27
  • (As of Friday Closing)

Guangdong Zhongsheng Pharmaceutical General Information

Description

Guangdong Zhongsheng Pharmaceutical Co Ltd is engaged in the pharmaceutical business. It is involved in the research and development, production and sales of pharmaceuticals, the cultivation of medicinal materials, and the processing of medicinal herbs, chemical raw material synthesis, and pharmaceutical trade.

Contact Information

Website
www.zspcl.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Information Industry Park, Xihu Industrial Zone
  • Shilong Town
  • Dongguan, Guangdong 523325
  • China
+86 0769
Primary Industry
Pharmaceuticals
Stock Exchange
SHE
Vertical(s)
Corporate Office
  • Information Industry Park, Xihu Industrial Zone
  • Shilong Town
  • Dongguan, Guangdong 523325
  • China
+86 0769

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Guangdong Zhongsheng Pharmaceutical Stock Performance

As of 20-Nov-2026, Guangdong Zhongsheng Pharmaceutical’s stock price is $3.27. Its current market cap is $2.78B with 850M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.27 $3.51 $2.41 - $5.06 $2.78B 850M 24.8M $0.03

Guangdong Zhongsheng Pharmaceutical Financials Summary

As of 30-Sep-2026, Guangdong Zhongsheng Pharmaceutical has a trailing 12-month revenue of $305M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 2,900,433 2,213,820 1,250,467 1,774,875
Revenue 304,959 350,803 343,869 368,989
EBITDA 30,436 58,063 (28,507) 59,522
Net Income 29,271 38,346 (41,692) 37,212
Total Assets 765,039 733,138 760,742 911,114
Total Debt 35,482 46,636 113,194 102,221
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Guangdong Zhongsheng Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Guangdong Zhongsheng Pharmaceutical‘s full profile, request access.

Request a free trial

Guangdong Zhongsheng Pharmaceutical Patents

Guangdong Zhongsheng Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026179803-A1 Heterocyclic compound against respiratory syncytial virus and use thereof Pending 28-Feb-2025
WO-2022237456-A1 Use of 4-arylaminoquinazoline hydroxamic acid compounds in preparation of pain drug Inactive 12-May-2021
WO-2021190337-A1 Salt form and crystal form of compound as smo inhibitor, and preparation method therefor Inactive 27-Mar-2020
WO-2021093733-A1 Quality control method for carbocisteine raw material and formulation thereof, and use thereof Inactive 11-Nov-2019
AU-2018361264-A1 Salt form and crystal form of compound as fgfr4 inhibitor and preparation method thereof Active 01-Nov-2017 A61P35/00
To view Guangdong Zhongsheng Pharmaceutical’s complete patent history, request access »

Guangdong Zhongsheng Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Guangdong Zhongsheng Pharmaceutical Investments & Acquisitions (7)

Guangdong Zhongsheng Pharmaceutical’s most recent deal was a Secondary Transaction - Private with Raynovent. The deal was made on 20-Sep-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Raynovent 20-Sep-2026 Secondary Transaction - Private Drug Discovery
Raynovent 01-Dec-2022 Later Stage VC Drug Discovery
QuadMedicine 09-May-2022 Later Stage VC Drug Delivery
ZhenShiMing 13-Dec-2021 Secondary Transaction - Private Pharmaceuticals
Raynovent 15-Dec-2020 Early Stage VC Drug Discovery
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Guangdong Zhongsheng Pharmaceutical ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

41.73 | Severe Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Guangdong Zhongsheng Pharmaceutical’s complete esg history, request access »

Guangdong Zhongsheng Pharmaceutical Exits (2)

Guangdong Zhongsheng Pharmaceutical’s most recent exit was on 09-May-2022 from QuadMedicine. The exit was categorized as with 8 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
QuadMedicine 09-May-2022 Completed
  • 8 buyers
Xuancheng Eye Hospital 14-Nov-2017 Merger/Acquisition Completed
To view Guangdong Zhongsheng Pharmaceutical’s complete exits history, request access »

Guangdong Zhongsheng Pharmaceutical Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Raynovent Guangzhou, China 2018
Hubei Lingsheng Pharmaceutical Company Xiangyang, China 2010

Guangdong Zhongsheng Pharmaceutical FAQs

  • When was Guangdong Zhongsheng Pharmaceutical founded?

    Guangdong Zhongsheng Pharmaceutical was founded in 1979.

  • Where is Guangdong Zhongsheng Pharmaceutical headquartered?

    Guangdong Zhongsheng Pharmaceutical is headquartered in Dongguan, China.

  • What is the size of Guangdong Zhongsheng Pharmaceutical?

    Guangdong Zhongsheng Pharmaceutical has 1,757 total employees.

  • What industry is Guangdong Zhongsheng Pharmaceutical in?

    Guangdong Zhongsheng Pharmaceutical’s primary industry is Pharmaceuticals.

  • Is Guangdong Zhongsheng Pharmaceutical a private or public company?

    Guangdong Zhongsheng Pharmaceutical is a Public company.

  • What is Guangdong Zhongsheng Pharmaceutical’s stock symbol?

    The ticker symbol for Guangdong Zhongsheng Pharmaceutical is 002317.

  • What is the current stock price of Guangdong Zhongsheng Pharmaceutical?

    As of 20-Nov-2026 the stock price of Guangdong Zhongsheng Pharmaceutical is $3.27.

  • What is the current market cap of Guangdong Zhongsheng Pharmaceutical?

    The current market capitalization of Guangdong Zhongsheng Pharmaceutical is $2.78B.

  • What is Guangdong Zhongsheng Pharmaceutical’s current revenue?

    The trailing twelve month revenue for Guangdong Zhongsheng Pharmaceutical is $305M.

  • What is Guangdong Zhongsheng Pharmaceutical’s annual earnings per share (EPS)?

    Guangdong Zhongsheng Pharmaceutical’s EPS for 12 months was $0.03.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process